Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
NCT07792668Phase 4Not yet recruiting
Phase 4, randomised, open-label trial of indomethacin and lidocaine in pain (3 arms), sponsored by Balıkesir University. Primary endpoint: Pain Intensity During Contrast-Medium Injection Measured Using the Numeric Rating Scale. Planned start Nov 2026; status: not yet recruiting.
Beyond the preview
Study design, results and competitive context are available in the Gosset platform where reported.
Available in the Gosset platform where reported.
Available in the Gosset platform where reported.
See how Gosset can support your research on NCT07792668.